Oxford Biomedica is a UK-based gene and cell therapy group. The article reports that the investment arm of Danish drugmaker Novo Nordisk is investing £53.5 million (about $67.5 million) in the company. The report identifies the investor as Novo Nordisk's investment arm and gives the amount in both pounds and dollars. The article excerpt does not specify the financing instrument, use of proceeds, or other participating investors. No operating metrics, past rounds, founding year, or additional financial details are provided in the excerpt.

Total raised

$68M

Funding rounds

1

Latest round

Equity

Latest activity

May 2019